• Alterations of the Gut Microbiome in Recurrent Malignant Gliomas Patients Received Bevacizumab and Temozolomide Combination Treatment and Temozolomide Monotherapy

    5 days ago - By Springer

    Abstract
    This case-control study explored compositions of gut microbiome in recurrent malignant gliomas patients who had received bevacizumab and Temozolomide combination treatment and Temozolomide monotherapy. We investigated gut microbiota communities in feces of 29 recurrent malignant gliomas patients received combination treatment with bevacizumab and Temozolomide and monotherapy with Temozolomide alone. We took advantage of the high-throughput Illumina Miseq sequencing technology by targeting the third and fourth hypervariable regions of the 16S ribosomal RNA gene. We found that the...
    Read more ...